Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001576885-25-000013
Filing Date
2025-01-07
Accepted
2025-01-07 19:55:46
Documents
1
Period of Report
2025-01-03

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1736297739.html 4  
1 FORM 4 wk-form4_1736297739.xml 4 8043
  Complete submission text file 0001576885-25-000013.txt   9501
Mailing Address 427 PARK ST. CHARLOTTESVILLE VA 22902
Business Address 427 PARK ST. CHARLOTTESVILLE VA 22902 925-368-8508
Acumen Pharmaceuticals, Inc. (Issuer) CIK: 0001576885 (see all company filings)

EIN.: 364108129 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O ACUMEN PHARMACEUTICALS, INC. 427 PARK STREET CHARLOTTESVILLE VA 22902
Business Address
Barton Russell (Reporting) CIK: 0001867418 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40551 | Film No.: 25516248